Cordcyte Market Report 2026

Cordcyte Market Overview

• The Cordcyte market growth in the historic period has been driven by advancement in stem cell transplantation, expansion of cord blood banking • Market expansion is supported by increased use in genetic disorders, regenerative medicine investments • Growth Driver: Rising Prevalence Of Chronic Diseases Driving Growth In The Cordcyte Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cordcyte Market?

Cordcyte is a therapeutic product made from human cord blood, specifically hematopoietic progenitor cells. It is used in allogeneic hematopoietic stem cell transplants, primarily for patients with hematopoietic system disorders, such as inherited conditions, or those resulting from treatments such as chemotherapy. These cells are infused into patients to support the regeneration of blood and immune systems. The main formulations of cordcyte are cord blood stem cells and cryopreserved units. Cord blood stem cells are powerful cells found in the umbilical cord blood that have the potential to develop into different types of cells. These cells are used in therapies to treat various medical conditions such as cancers, blood diseases, and immune disorders. They are preferred because they are less likely to cause rejection when transplanted. It is used for various indications such as hematological disorders, genetic disorders, and immune system disorders and is distributed through channels such as hospital pharmacies, stem cell banks, and outpatient clinics.

What Is The Cordcyte Market Growth Forecast?

The growth in the forecast period can be attributed to increased use in genetic disorders, regenerative medicine investments, expansion of transplant infrastructure, improved matching technologies, global stem cell banking growth. Major trends in the forecast period include growth in cord blood stem cell transplantation, expansion of allogeneic cell therapies, rising demand for regenerative treatments, improved cryopreservation technologies, specialized transplant center development.

Global Cordcyte Market Segmentation

1) By Formulation: Cord Blood Stem Cells, Cryopreserved Units 2) By Indication: Hematological Disorders, Genetic Disorders, Immune System Disorders 3) By Distribution Channel: Hospital Pharmacies, Stem Cell Banks, Outpatient Clinics

What Are The Drivers Of The Cordcyte Market?

The increasing number of chronic diseases is expected to propel the growth of the cordcyte market going forward. Chronic diseases refer to long-lasting conditions that require ongoing management and treatment. The prevalence of chronic diseases is increasing due to factors such as an aging population, poor lifestyle choices, and environmental influences. Cordcyte is used in clinical diseases for regenerative therapy, leveraging stem cells from umbilical cord blood to treat conditions such as hematological disorders, immune deficiencies, and neurodegenerative diseases. For instance, in September 2025, according to the British Heart Foundation, a UK-based charity, across the UK, more than 7.6 million people over 4 million men and more than 3.6 million women are living with cardiovascular disease, and projections indicate that, driven by an aging population and improved survival rates, the number of affected individuals may rise by around 1 million by 2030 and by approximately 2 million by 2040. Therefore, the increasing prevalence of chronic diseases will drive the growth of the cordcyte industry. The rising clinical trials are expected to accelerate the growth of the cordcyte market going forward. The rise in clinical trials is driven by increasing demand for innovative treatments, advancements in stem cell technologies, and regulatory support for new therapeutic applications. Clinical trials boost cordcyte by demonstrating its safety and efficacy, leading to regulatory approvals and increased adoption in treatments. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, the number of gene therapies in Phase III clinical trials grew by 10% in Q3 2023, the first quarterly increase since Q3 2022. Therefore, the rising clinical trials are driving the growth of the cordcyte industry. The increasing healthcare expenditure is expected to propel the growth of the cordcyte market going forward. Healthcare expenditure refers to the total spending on health services and products within a specific period. The increase in healthcare expenditure is driven by factors such as an aging population, rising healthcare costs, and advancements in medical technology. Healthcare expenditure plays a critical role in advancing cordcyte applications by funding research, clinical trials, and infrastructure, enabling broader access and development of regenerative therapies for complex diseases. For instance, in April 2025, according to the Office for National Statistics (ONS), a UK-based independent producer of official statistics, total healthcare expenditure rose by 6.5% in nominal terms and 2.4% in real terms between 2023 and 2024, while healthcare’s share of GDP held steady at 11.1% in 2024, matching the previous year. Therefore, the increasing healthcare expenditure is driving the growth of the cordcyte industry.

Key Players In The Global Cordcyte Market

Major companies operating in the cordcyte market are LifeSouth Community Blood Centers Inc.

Regional Insights

North America was the largest region in the cordcyte market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Cordcyte Market?

The cordcyte market consists of sales of exosome-based products, stem cell transplants, and cell storage devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cordcyte Market Report 2026?

The cordcyte market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cordcyte industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.